ClinicalTrials.govpublic full text
Toripalimab Plus Celecoxib for dMMR/MSI-H Locally Advanced Colorectal Cancer
colorectal cancer, microsatellite instability high, mismatch repair deficiency, pd-1 blockade, toripalimab, cox-2 inhibitor, celecoxib, non-operative management, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1033275
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.